EVIDENCE LIBRARY
Mouse Development Study Found Different Diazepam-Sensitive Windows for Later Anxiety-Like and Swim Behavior
A developmental experiment linked the timing of transient diazepam exposure to different adult behavioral outcomes. The mouse age windows were not human clinical dosing guidance.
A developmental experiment linked the timing of transient diazepam exposure to different adult behavioral outcomes. The mouse age windows were not human clinical dosing guidance.
The timing findings
Diazepam given during postnatal days ten through sixteen was associated with increased adult anxiety-like behavior in the elevated plus maze. Exposure during days twenty-nine through thirty-five instead increased immobility in the forced-swim test.
Genetic manipulation of a GABA-A receptor subunit provided a separate line of evidence about developmental timing. Some behavioral changes occurred without altered adult hippocampal neurogenesis.
Behavioral models have boundaries
Maze exploration and forced-swim immobility are experimental endpoints rather than diagnoses of human anxiety or depression. Genetic reduction of receptor function is also different from pharmacologic potentiation.
The study cannot establish equivalent critical periods in children, predict an individual outcome, or quantify clinical risk from a prescription. It supports retaining developmental stage and endpoint when interpreting experimental exposure. A single generic statement that early diazepam changes behavior would omit the different timing and distinct measures.
Source paper
Original analysis of the supplied journal article, identified as PMC3469546.